1-[4-(benzyloxy)phenyl]-4,4,4-trifluoro-3-hydroxybut-2-en-1-one, 95%, 500mg

1-(5-Amino-2-bromophenyl)ethanone, 95%, 100mg

(R)-2-Amino-3-(m-tolyl)propanoic acid, 95.0%, 25g

Fmoc-D-Lys(Boc)-OH, >98%, 25g

5-Bromo-2-ethyl-1H-pyrrolo[2,3-b]pyridine, 97%, 100mg

Zernike phase contrast kit with PLPH i Plan phase 10/20/S40/S100 oil immersion IOS objectives, rotating Zernike condenser, telescope and green filter

4,6-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)dibenzo[b,d]furan, 98%, 100mg

4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide, 95.0%, 1g

adamantane-1-carbonyl chloride, 95.0%, 1g

3-Bromopyrazolo[1,5-a]pyridin-2-ol, 95.0%, 100mg

5-AMINOBENZENE-1,3-DINITRILE, 95.0%, 1g

Phenyl(tetrahydro-2H-pyran-4-yl)methanone, 97%, 1g

Bis[(2-diphenylphosphino)phenyl] ether, 95.0%, 100g